LPL Financial’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$459K Sell
43,741
-798
-2% -$7.79K ﹤0.01% 4838
2025
Q4
$512K Sell
44,539
-2,473
-5% -$38.2K ﹤0.01% 4692
2025
Q3
$1.14M Sell
47,012
-57,854
-55% -$964K ﹤0.01% 3872
2025
Q2
$1.73M Buy
104,866
+18,925
+22% +$327K ﹤0.01% 3268
2025
Q1
$1.56M Buy
85,941
+20,009
+30% +$572K ﹤0.01% 3171
2024
Q4
$2.45M Sell
65,932
-2,547
-4% -$97.5K ﹤0.01% 2685
2024
Q3
$2.19M Buy
68,479
+9,362
+16% +$520K ﹤0.01% 2640
2024
Q2
$4.85M Buy
59,117
+7,232
+14% +$782K ﹤0.01% 1877
2024
Q1
$7.52M Buy
51,885
+6,545
+14% +$553K ﹤0.01% 1509
2023
Q4
$4.18M Buy
45,340
+2,925
+7% +$297K ﹤0.01% 1805
2023
Q3
$7M Buy
42,415
+9,140
+27% +$1.19M ﹤0.01% 1391
2023
Q2
$2.1M Buy
33,275
+8,141
+32% +$493K ﹤0.01% 2206
2023
Q1
$853K Buy
25,134
+2,533
+11% +$132K ﹤0.01% 2864
2022
Q4
$1.31M Sell
22,601
-4,917
-18% -$304K ﹤0.01% 2428
2022
Q3
$2.59M Buy
27,518
+8,212
+43% +$1.17M ﹤0.01% 1794
2022
Q2
$4.31M Buy
19,306
+5,595
+41% +$1.87M ﹤0.01% 1503
2022
Q1
$7.54M Buy
13,711
+862
+7% +$521K 0.01% 1170
2021
Q4
$8.49M Buy
12,849
+522
+4% +$399K 0.01% 1123
2021
Q3
$10.3M Buy
12,327
+2,664
+28% +$2.7M 0.01% 944
2021
Q2
$12.3M Buy
9,663
+2,628
+37% +$2.97M 0.01% 805
2021
Q1
$7.72M Buy
7,035
+230
+3% +$304K 0.01% 959
2020
Q4
$9.71M Buy
+6,805
New +$7.26M 0.01% 760
2020
Q3
Sell
-694
Closed -$485K 3561
2020
Q2
$485K Buy
+694
New +$401K ﹤0.01% 2413

Other funds holding CDLX

LPL Financial's CDLX Position: Q1 2026 in Review

LPL Financial reduced its Cardlytics (CDLX) stake by 1.8% in Q1 2026, selling an estimated $7.79K and leaving 43,741 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #4838.

LPL Financial first reported a position in CDLX in Q2 2020 and has held it in 23 quarters since. The position peaked at $12.3M in Q2 2021. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • LPL Financial held 43,741 shares of Cardlytics worth $459K as of Q1 2026.
  • LPL Financial sold 798 Cardlytics shares in Q1 2026, an estimated $7.79K.
  • Cardlytics made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #4838 holding.
  • LPL Financial first reported a position in Cardlytics in Q2 2020 and has held it in 23 quarters since.
  • LPL Financial's Cardlytics position peaked at $12.3M in Q2 2021.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.